{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T21:15:18Z","timestamp":1769116518420,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"WHO-AFRO\/EDCTP\/TDR","award":["202229181"],"award-info":[{"award-number":["202229181"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>HIV-infected persons are at increased risk of developing tuberculosis and Isoniazid preventive therapy has been shown to reduce the occurrence of tuberculosis among this group of persons. M-health technology has been reported to increase both knowledge and implementation of various health services including Isoniazid preventive therapy implementation. This study aimed to determine the effect of m-health on health worker knowledge and adherence to isoniazid preventive therapy (IPT) guidelines and on patient knowledge and adherence to isoniazid treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a quasi-experimental study that was carried out in six health facilities\u00a0in Ebonyi State, southeast Nigeria. Three health facilities were assigned to each arm (intervention and control arms) and all eligible health workers (total population of 45 and 41 in intervention and control arms respectively) were recruited. Data were also collected from 200 patients (100 per arm). The intervention consisted of mobile phone messages and reminders for health workers on the IPT guideline. Chi-square test was carried out at p\u2009&lt;\u20090.05 and 95% confidence interval.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>At baseline, 54.5% and 63.4% of health workers in intervention and control arms respectively had good knowledge which improved significantly to 90.2% in the intervention arm after the intervention (<jats:italic>\u03c7<\/jats:italic><jats:sup><jats:italic>2<\/jats:italic><\/jats:sup>\u2009=\u200914.22, p\u2009&lt;\u20090.0001). At baseline, 61.4% and 90.2% of health workers had good adherence to the guideline in intervention and control arms respectively which also improved in the intervention arm by 28.8% after intervention although not significant(<jats:italic>\u03c7<\/jats:italic><jats:sup><jats:italic>2<\/jats:italic><\/jats:sup>\u2009=\u20090.37, p\u2009=\u20090.54). More than 50% of the patients in both study arms had poor knowledge, with the intervention arm having a significantly higher proportion of respondents (68.0%) with poor knowledge at baseline (<jats:italic>\u03c7<\/jats:italic><jats:sup><jats:italic>2<\/jats:italic><\/jats:sup>\u2009=\u20094.71, p\u2009=\u20090.03). The proportion of patients with good knowledge however increased significantly (88.8%) in the intervention arm after intervention (<jats:italic>\u03c7<\/jats:italic><jats:sup><jats:italic>2<\/jats:italic><\/jats:sup>\u2009=\u200925.65, p\u2009&lt;\u20090.001). Patients had good adherence to IPT in intervention and control arms before (100% and 84.2% respectively) and after (96.6% and 100% respectively) the study. There was no significant difference in adherence among patients in both arms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Health worker knowledge and practice of guidelines as well as patient knowledge improved in the intervention arm in this study. These findings suggest the consideration for the inclusion of mobile phone reminders in the guideline for tuberculosis prevention among HIV patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-021-06759-4","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T14:01:51Z","timestamp":1634652111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effect of mobile-phone messaging on patient and health-worker knowledge and adherence to the isoniazid preventive therapy guideline in HIV clinics in Southeast, Nigeria"],"prefix":"10.1186","volume":"21","author":[{"given":"Ifeyinwa Chizoba","family":"Akamike","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ijeoma Nkem","family":"Okedo-Alex","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihurumnanya","family":"Alo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adaoha Pearl","family":"Agu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chigozie Jesse","family":"Uneke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence Ulu","family":"Ogbonnaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"issue":"8","key":"6759_CR1","first-page":"927","volume":"13","author":"E Alarcon","year":"2015","unstructured":"Alarcon E, Bissell K, Boillot F, Caminero JA, Chiang C, Clevenbergh P, et al. Isoniazid preventive therapy for people living with HIV\u202f: public health challenges and implementation issues. Int J Tuberc Lung Dis. 2015;13(8):927\u201335.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"6759_CR2","doi-asserted-by":"publisher","first-page":"e87166","DOI":"10.1371\/journal.pone.0087166","volume":"9","author":"T Makanjuola","year":"2014","unstructured":"Makanjuola T, Taddese HB, Booth A. Factors associated with adherence to treatment with isoniazid for the prevention of tuberculosis amongst people living with HIV\/AIDS: a systematic review of qualitative data. PLoS ONE. 2014;9(2):e87166.","journal-title":"PLoS ONE"},{"key":"6759_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5799\/ahinjs.02.2015.02.0175","volume":"5","author":"Y Getachew","year":"2015","unstructured":"Getachew Y, Mekonnen W. Correlates of adherence and utilization of Isoniazid preventive therapy in HIV patients. J Microbiol Infect Dis. 2015;5:45\u201350.","journal-title":"J Microbiol Infect Dis"},{"key":"6759_CR4","unstructured":"Isoniazid Preventive Therapy (IPT) for the Prevention of Tuberculosis in People Living with HIV (e-course)|FHI 360. https:\/\/www.fhi360.org\/resource\/isoniazid-preventive-therapy-ipt-prevention-tuberculosis-people-living-hiv-e-course."},{"issue":"5","key":"6759_CR5","first-page":"1208","volume":"36","author":"N Hiransuthikul","year":"2005","unstructured":"Hiransuthikul N, Hiransuthikul P, Nelson KE, Jirawisit M, Paewplot R, Kasak S, et al. Physician adherence to isoniazid preventive therapy guidelines for HIV infected patients in Thailand. Southeast Asian J Trop Med Public Heal. 2005;36(5):1208\u201315.","journal-title":"Southeast Asian J Trop Med Public Heal"},{"key":"6759_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/1472-698X-12-2","author":"A Wesen","year":"2012","unstructured":"Wesen A, Mitike G. Provision and awareness for isoniazid preventive therapy among PLHIV in Addis Ababa, Ethiopia. BMC Int Health Hum Rights. 2012. https:\/\/doi.org\/10.1186\/1472-698X-12-2.","journal-title":"BMC Int Health Hum Rights"},{"issue":"1","key":"6759_CR7","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1186\/s12889-016-3525-8","volume":"16","author":"G Teklay","year":"2016","unstructured":"Teklay G, Teklu T, Legesse B, Tedla K, Klinkenberg E. Barriers in the implementation of isoniazid preventive therapy for people living with HIV in Northern Ethiopia: a mixed quantitative and qualitative study. BMC Public Health. 2016;16(1):840. https:\/\/doi.org\/10.1186\/s12889-016-3525-8.","journal-title":"BMC Public Health"},{"key":"6759_CR8","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/1471-2458-12-468","volume":"12","author":"ND Goswami","year":"2012","unstructured":"Goswami ND, Gadkowski LB, Piedrahita C, Bissette D, Ahearn MA, Blain MLM, et al. Predictors of latent tuberculosis treatment initiation and completion at a U. S. public health clinic\u202f: a prospective cohort study. BMC Public Health. 2012;12:468.","journal-title":"BMC Public Health"},{"issue":"1","key":"6759_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/1471-2334-14-281","volume":"14","author":"LV Adams","year":"2014","unstructured":"Adams LV, Talbot EA, Odato K, Blunt H, Steingart KR. Interventions to improve delivery of isoniazid preventive therapy: an overview of systematic reviews. BMC Infect Dis. 2014;14(1):281.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"6759_CR10","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1590\/0102-311X00154614","volume":"31","author":"ADS De","year":"2015","unstructured":"De ADS, Paula A. Factors associated with treatment for latent tuberculosis in persons living with HIV \/ AIDS Fatores associados ao tratamento da tuberculose latente em pessoas vivendo com HIV\/AIDS Factores asociados al tratamiento de la tuberculosis latente en personas. Cad sa\u00fade p\u00fablica. 2015;31(12):2505\u201313.","journal-title":"Cad sa\u00fade p\u00fablica"},{"issue":"1","key":"6759_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/00002030-199701000-00016","volume":"11","author":"J Ngamvithayapong","year":"1996","unstructured":"Ngamvithayapong J, Uthaivoravit W, Yanai H, Akarasewi P, Sawanpanyalert P. Adherence to tuberculosis preventive therapy among HIV-infected persons in Chiang Rai, Thailand. AIDS. 1996;11(1):107\u201312.","journal-title":"AIDS"},{"key":"6759_CR12","doi-asserted-by":"crossref","unstructured":"Yamin A, Bornstein E, Hensel R, Mohamed O, Kempker RR. Predictors of latent tuberculosis infection treatment after introduction of a new regimen\u202f: a retrospective cohort study at an inner city clinic. Open Forum Infect Dis. 2016;(Cdc):1\u20136.","DOI":"10.1093\/ofid\/ofw082"},{"key":"6759_CR13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s12879-015-1085-7","volume":"15","author":"GA Shayo","year":"2015","unstructured":"Shayo GA, Moshiro C, Aboud S, Bakari M, Mugusi FM. Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania. BMC Infect Dis. 2015;15:368.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"6759_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4321\/S1886-36552009000200001","volume":"7","author":"MP Schneider","year":"2009","unstructured":"Schneider MP, Krummenacher I, Figueiredo H, Marquis J, Bugnon O. Adherence: a review of education, research, practice and policy in Switzerland. Pharm Pract (Granada). 2009;7(2):63\u201373.","journal-title":"Pharm Pract (Granada)"},{"key":"6759_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/230587","volume":"2014","author":"M Berhe","year":"2014","unstructured":"Berhe M, Demissie M, Tesfaye G. Isoniazid preventive therapy adherence and associated factors among HIV positive patients in Addis Ababa, Ethiopia. Adv Epiemiol. 2014;2014:1.","journal-title":"Adv Epiemiol."},{"issue":"1","key":"6759_CR16","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1186\/1471-2458-11-916","volume":"11","author":"M Mindachew","year":"2011","unstructured":"Mindachew M, Deribew A, Tessema F, Biadgilign S, Smoll M, Shafer F, et al. Predictors of adherence to isoniazid preventive therapy among HIV positive adults in Addis Ababa, Ethiopia. BMC Public Health. 2011;11(1):916.","journal-title":"BMC Public Health"},{"key":"6759_CR17","unstructured":"Federal Ministry of Health Department of public health. Guideline for isoniazid preventive therapy. 2014."},{"key":"6759_CR18","first-page":"5","volume":"3","author":"World Health Organisation","year":"2011","unstructured":"World Health Organisation. mHealth: new horizons for health through mobile technologies. Glob Obs eHealth Ser. 2011;3:5\u20136.","journal-title":"Glob Obs eHealth Ser"},{"key":"6759_CR19","first-page":"482324","volume":"2013","author":"TJ Betjeman","year":"2013","unstructured":"Betjeman TJ, Soghoian SE, Foran MP. mHealth in Sub-Saharan Africa. Int J Telemed Appl. 2013;2013:482324.","journal-title":"Int J Telemed Appl"},{"issue":"1","key":"6759_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/1471-2393-14-284","volume":"14","author":"YK Lau","year":"2014","unstructured":"Lau YK, Cassidy T, Hacking D, Brittain K, Haricharan HJ, Heap M. Antenatal health promotion via short message service at a Midwife Obstetrics Unit in South Africa: a mixed methods study. BMC Pregnancy Childbirth. 2014;14(1):284.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"6759_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/07448481.2015.1117466","volume":"64","author":"AR Richman","year":"2016","unstructured":"Richman AR, Maddy L, Torres E, Goldberg EJ. A randomized intervention study to evaluate whether electronic messaging can increase human papillomavirus vaccine completion and knowledge among college students. J Am Coll Heal. 2016;64(4):269\u201378.","journal-title":"J Am Coll Heal"},{"issue":"1","key":"6759_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5993\/AJHB.40.1.8","volume":"40","author":"HY Lee","year":"2016","unstructured":"Lee HY, Koopmeiners JS, McHugh J, Raveis VH, Ahluwalia JS. mhealth pilot study: text messaging intervention to promote HPV vaccination. Am J Health Behav. 2016;40(1):67\u201376.","journal-title":"Am J Health Behav"},{"issue":"5","key":"6759_CR23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3928\/01484834-20150417-08","volume":"54","author":"R Schnall","year":"2015","unstructured":"Schnall R. Short message service use in clinical care through a simulation activity. J Nurs Educ. 2015;54(5):290\u20134. https:\/\/doi.org\/10.3928\/01484834-20150417-08.","journal-title":"J Nurs Educ"},{"issue":"3","key":"6759_CR24","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4103\/1119-3077.113451","volume":"16","author":"O Maduka","year":"2013","unstructured":"Maduka O, Tobin-West CI. Adherence counseling and reminder text messages improve uptake of antiretroviral therapy in a tertiary hospital in Nigeria. Niger J Clin Pract. 2013;16(3):302\u20138.","journal-title":"Niger J Clin Pract"},{"issue":"1","key":"6759_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/epirev\/mxq004","volume":"32","author":"C-L Heather","year":"2010","unstructured":"Heather C-L, Kershaw T. Text messaging as a tool for behavior change in disease prevention and management. Epidemiol Rev. 2010;32(1):56\u201369.","journal-title":"Epidemiol Rev"},{"key":"6759_CR26","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1186\/1471-2334-13-566","volume":"13","author":"MD Nglazi","year":"2013","unstructured":"Nglazi MD, Bekker L, Wood R, Hussey GD, Wiysonge CS. Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment\u202f: a systematic review. BMC Infect Dis. 2013;13:566.","journal-title":"BMC Infect Dis"},{"key":"6759_CR27","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/bmj.325.7370.954","volume":"325","author":"MM Kitahata","year":"2002","unstructured":"Kitahata MM, Tegger MK, Wagner EH, Holmes KK. Comprehensive health care for people infected with HIV in developing countries. BMJ. 2002;325:954\u20137.","journal-title":"BMJ"},{"issue":"11","key":"6759_CR28","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.5588\/ijtld.13.0315","volume":"17","author":"S Zaeh","year":"2013","unstructured":"Zaeh S, Kempker R, Stenehjem E, Blumberg HM, Temesgen O, Ofotokun I, et al. Improving tuberculosis screening and isoniazid preventive therapy in an HIV clinic in Addis Ababa, Ethiopia. Int J Tuberc Lung Dis. 2013;17(11):1396\u2013401.","journal-title":"Int J Tuberc Lung Dis"},{"key":"6759_CR29","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2020.36.261.22496","author":"IC Akamike","year":"2020","unstructured":"Akamike IC, Okedo-Alex IN, Agu AP, Alo C, Ogbonnaya LU. Knowledge and adherence to isoniazid preventive therapy among people living with HIV (PLHIV) in multilevel health facilities in South-East, Nigeria: baseline findings from a quasi-experimental study. Pan Afr Med J. 2020. https:\/\/doi.org\/10.11604\/pamj.2020.36.261.22496.","journal-title":"Pan Afr Med J"},{"key":"6759_CR30","unstructured":"Tikuye AM, Tikuye AM. Knowledge, attitudes and practices of health care providers towards isoniazide preventive therapy (IPT) provision in Addis Ababa, Ethiopia; 2013."},{"issue":"1","key":"6759_CR31","first-page":"46","volume":"29","author":"BM Lawan","year":"2018","unstructured":"Lawan BM, Agu KA. Assessment of short term Isoniazid Preventive Therapy ( IPT ) in people living with HIV\/AIDS. West Afr J Pharm. 2018;29(1):46\u201358.","journal-title":"West Afr J Pharm"},{"issue":"5","key":"6759_CR32","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1183\/09031936.00125611","volume":"39","author":"D Manissero","year":"2012","unstructured":"Manissero D, Marieke J, Langendam M, Huitric E. Knowledge of tuberculosis-treatment prescription of health workers: a systematic review. Eur Respir J. 2012;39(5):1248\u201355.","journal-title":"Eur Respir J"},{"issue":"3","key":"6759_CR33","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.4314\/ahs.v20i3.10","volume":"20","author":"IC Akamike","year":"2020","unstructured":"Akamike IC, Okedo-alex IN, Uneke CJ, Uro-chukwu C, Chukwu OE, Ugwu NI, et al. Evaluation of the effect of an educational intervention on knowledge and adherence to HIV guidelines among frontline health workers in Alex-Ekwueme Federal University Teaching Hospital Abakaliki, Nigeria. Afr Health Sci. 2020;20(3):1080\u20139.","journal-title":"Afr Health Sci"},{"key":"6759_CR34","doi-asserted-by":"crossref","unstructured":"Abdulrazaak AT, Govender I, Nzaumvila D, Group F. Knowledge , attitudes and practices of doctors regarding isoniazid preventive therapy in HIV\/AIDS patients at Odi District Hospital, Gauteng province, South Africa Knowledge , attitudes and practices of doctors regarding isoniazid preventive therapy i. South African J Infect Dis. 2018;0053.","DOI":"10.1080\/23120053.2018.1548726"},{"key":"6759_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2458-14-52","volume":"14","author":"AW Denegetu","year":"2014","unstructured":"Denegetu AW, Dolamo BL. Tuberculosis case finding and isoniazid preventive therapy among people living with HIV at public health facilities of Addis Ababa, Ethiopia\u202f: a cross-sectional facility based study. BMC Public Health. 2014;14:52.","journal-title":"BMC Public Health"},{"key":"6759_CR36","unstructured":"Ngombo AM. Factors affecting implementation of isoniazid preventive therapy in HIV\/AIDS clinics in Dar es Salaam Region, Tanzania. 2013;"},{"issue":"3","key":"6759_CR37","first-page":"249","volume":"15","author":"V Saraceni","year":"2011","unstructured":"Saraceni V, Antonio G, Jonathan G, Victoria V, Bonnie K, Solange C, et al. Physician adherence to guidelines for tuberculosis and HIV care in Rio de Janeiro, Brazil. Brazilian J Infect Dis. 2011;15(3):249\u201352.","journal-title":"Brazilian J Infect Dis"},{"issue":"9","key":"6759_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1001876","volume":"12","author":"X Liu","year":"2015","unstructured":"Liu X, Lewis JJ, Zhang H, Lu W, Zhang S, Zheng G, et al. Effectiveness of electronic reminders to improve medication adherence in tuberculosis patients: a cluster-randomised. PLoS Med. 2015;12(9):1\u201318.","journal-title":"PLoS Med"},{"key":"6759_CR39","unstructured":"National Telehealth Technology Assessment Resource Center. mHealth - Technology Overview. www.telehealthtechnology.org\/toolkits\/mhealth\/about-this-technology\/technology-overview."},{"key":"6759_CR40","unstructured":"World Health Organization. Global diffusion of eHealth, Making universal health coverage achievable: report on the Third Global Survey on eHealth Geneva. 2016."},{"key":"6759_CR41","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s11096-015-0086-3","volume":"37","author":"O Awwad","year":"2015","unstructured":"Awwad O, Akour A, Al-Muhaissen S, Morisky D. The influence of patients\u2019 knowledge on adherence to their chronic medications: a cross-sectional study in Jordan. Int J Clin Pharm. 2015;37:504.","journal-title":"Int J Clin Pharm"},{"key":"6759_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006594.pub3","author":"Q Liu","year":"2014","unstructured":"Liu Q, Abba K, Mm A, Sinclair D, Vm B, Mad L. Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment (Review). Cochrane Database. 2014. https:\/\/doi.org\/10.1002\/14651858.CD006594.pub3.","journal-title":"Cochrane Database"},{"key":"6759_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-014-0654-6","author":"L Mbuagbaw","year":"2015","unstructured":"Mbuagbaw L, Mursleen S, Lytvyn L, Smieja M, Dolovich L, Thabane L. Mobile phone text messaging interventions for HIV and other chronic diseases: an overview of systematic reviews and framework for evidence transfer. BMC Health Serv Res. 2015. https:\/\/doi.org\/10.1186\/s12913-014-0654-6.","journal-title":"BMC Health Serv Res"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06759-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06759-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06759-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T14:08:46Z","timestamp":1634652526000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06759-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6759"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06759-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,19]]},"assertion":[{"value":"21 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the research and ethics committee of Alex Ekwueme Federal University Teaching Hospital with REC approval number: 18\/01\/2017-09\/03\/2017. Permission to carry out the study was obtained from the management of health facilities that were selected for the study. Written informed consent was obtained from the respondents after explaining fully the purpose of the study and their rights as participants. Confidentiality was ensured and participation in the study was voluntary. All methods were carried out in accordance with relevant guidelines and regulations\/Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they do not have any conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1080"}}